欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2988/001
药品名称
Buprenorphine 2 mg Sublingual Tablets
活性成分
buprenorphine hydrochloride 2.0 mg
剂型
Sublingual tablet
上市许可持有人
SANDOZ LIMITED
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 04416/0948 - 0012
Sweden (SE)
Buprenorphine Sandoz
Norway (NO)
许可日期
2011/07/06
最近更新日期
2022/09/14
药物ATC编码
N07BC01 buprenorphine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
con286926_pdf
Date of last change:2024/09/06
Final Labelling
|
1_3_1 spc_label_pl _ common_outer _ 5_289_clean
Date of last change:2024/09/06
Final PL
|
1_3_1 spc_label_pl _ common_pl _ 12_835
Date of last change:2024/09/06
Final SPC
|
1_3_1 spc_label_pl _ common_spc _ 12_373
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase